scholarly journals 11THE EFFECT OF PRESYNCHRONIZATION ON PREGNANCY RATE TO FIXED-TIME AI IN BEEF HEIFERS SUBJECTED TO A COSYNCH PROTOCOL

2004 ◽  
Vol 16 (2) ◽  
pp. 128 ◽  
Author(s):  
M.G. Colazo ◽  
J.A. Small ◽  
D.R. Ward ◽  
N.E. Erickson ◽  
J.P. Kastelic ◽  
...  

The objective was to investigate the effect of presynchronization with PGF prior to a Cosynch protocol on estrus synchrony, CL and preovulatory follicle diameters and pregnancy rate following timed-AI (TAI) in beef heifers. Cycling beef heifers (n=148) were treated with 100μg GnRH i.m. (Cystorelin, Merial Canada Inc., Victoriaville, Quebec, Canada) on Day 0, 500μg cloprostenol i.m. (PGF; Estrumate, Schering Plough Animal Health, Pointe-Claire, Quebec, Canada) on Day 7, and GnRH concurrent with TAI on Day 9 (54h after PGF). Half of the heifers (Control) received the first GnRH treatment at random stages of the estrous cycle, while the other half (Presynch) received two injections of PGF 11 days apart, with the first injection of GnRH 11 days after the second injection of PGF. Estrus detection was done between the first GnRH and 12h after PGF, and heifers detected in estrus were inseminated (and considered nonpregnant to TAI), while all other heifers were TAI. Heifers were examined by transrectal ultrasonography for CL and follicle development, and confirmation of pregnancy. Data were compared between groups using Student’s t-test and chi-square procedures. The numbers of heifers in estrus early (after first GnRH and before TAI) was higher in the Control group than in the Presynch group (18/74 v. 2/74, respectively; P<0.0001). Mean (±SD) diameters of the dominant follicle (12.1±3.1 v. 14.2±2.5mm) and CL (17.3±5.5v. 20.5±4.3mm) at first GnRH injection were smaller (P<0.0001) and more variable (P<0.03) in Control than Presynch heifers, but diameters of the preovulatory follicle (P=0.3) and CL (P=0.1) at TAI did not differ. Although the diameter of the preovulatory follicle was more variable (P<0.004) in Control (5 to 19mm) than Presynch (8 to 17mm) heifers, pregnancy rate to TAI did not differ (P=0.4; 29.7 v. 36.5%, respectively). Overall pregnancy rates were 45.9 and 37.8% for Control and Presynch groups, respectively (P=0.3). Pregnancy rate tended (P<0.08) to be affected by diameter of the preovulatory follicle at the time of TAI (0, 23.1, 45.7, 41.4, and 60.0% pregnant for diameters of <9, 9–11, 12–14, 15–17, and >17mm, respectively). Regardless of treatment, diameter of the preovulatory dominant follicle (P<0.02) and CL (P<0.03) 7 days after TAI was smaller, and CL diameter was more variable (P<0.004), in open than in pregnant heifers (12.7±2.6v. 13.8±2.1mm, and 16.5±4.4v. 18.0±3.0mm, respectively). In summary, presynchronization with PGF prior to a Cosynch protocol reduced the proportion of heifers in estrus before TAI, suggesting that this approach may be useful in the successful application of Ovsynch or Cosynch programs in heifers. However, pregnancy rate to TAI did not differ between groups in this study. Diameter of the preovulatory follicle tended to positively affect pregnancy rate, regardless of treatment.

2008 ◽  
Vol 20 (1) ◽  
pp. 90 ◽  
Author(s):  
L. F. Pfeifer ◽  
R. Mapletoft ◽  
G. Adams ◽  
J. Kastelic ◽  
J. Small ◽  
...  

The objective was to determine the effect of the level of progesterone (P4) during the ovulatory wave on fertility. Low v. high progesterone concentrations which were expected to result in high v. low LH pulse-frequency were compared. Lactating, postpartum beef cows (n = 69) at random stages of the estrous cycle were given cloprostenol (PGF; Schering-Plough Animal Health, Pointe-Claire, QC, Canada) twice at an 11-day interval to synchronize ovulation (Day 0 = day of 2nd PGF). Cows were given 1.5 mg estradiol benzoate on Day 10 (7 days after expected ovulation). On Day 10, the Low-P4 group was given PGF and an intravaginal CueMate (Bioniche Animal Health, Belleville, ON, Canada) containing one P4 pod (expected to achieve a P4 plasma level of 1 ng mL–1). The High-P4 group also received a CueMate with one pod on Day 10, but no PGF was administered (i.e., cows were allowed to retain their CL for 4 days after expected emergence of the estradiol-induced wave). On Day 18, CueMates were removed and PGF was administered to both groups. Fifty-four to 56 h later, all animals received 12.5 mg of Lutropin-V (Bioniche) IM and were timed AI (TAI). Dominant follicle diameter was measured on Day 18 and at the time of AI. Pregnancy diagnosis was done by ultrasonography 27 days after AI to compare fertility between groups. Follicle diameter data were analyzed by Student's t-test and pregnancy rate data were compared by the chi-square test. The dominant follicle in the Low-P4 group was larger (P < 0.05) than in the high-P4 group on the day of the CueMate removal (Day 18) and on the day of the TAI (11.8 � 0.4 and 13.7 � 0.5 v. 13.3 � 0.6 and 15.3 � 0.6 in the High-P4 and Low-P4 groups, respectively). Pregnancy rate was similar (P = 0.16) between the groups (High-P4: 55.6% (20/36) and Low-P4: 44.4% (16/33)); however, a larger study is in progress to confirm these results. To conclude, Low-P4 resulted in a larger dominant follicle without any apparent effect on pregnancy rate. The project was funded by Saskatchewan ADF and NSERC. L. Pfeifer is funded through a CAPES scholarship. We acknowledge Schering-Plough and Bioniche for donation of pharmaceuticals.


2014 ◽  
Vol 26 (1) ◽  
pp. 119
Author(s):  
J. B. S. Borges ◽  
D. X. Thedy

Successful establishment of pregnancy in the cow depends on early rise of progesterone (P4) to improve embryo development. The present study was carried out to determine the corpus luteum (CL) function and pregnancy rate following the administration of 1.500 IU of hCG in suckled beef cows on Day 4 after fixed-time AI (FTAI). Crossbred Angus cows (n = 429), 40 to 70 days postpartum, were synchronized using 2 mg of oestradiol benzoate (EB) i.m. and an intravaginal progesterone-releasing device containing 1 g of P4 for 7 days. At device removal, prostaglandin F2a (150 mg of D-cloprostenol) was injected i.m.; 24 h later, 1 mg of EB was given and the FTAI were done 30 to 36 h after EB using semen of just 1 bull. Cows were assigned alternatively to receive 1.500 IU of hCG i.m. (n = 200) or 1 mL of saline i.m. (n = 229) on Day 4 after FTAI. Ovaries were examined by transrectal ultrasonography (n = 71) on Days 4 and 7 to detect the presence and to measure the area of CL. Blood samples were collected on Days 4, 7, 10, 14, and 30 post-oestrus to determine P4 concentration by RIA. Pregnancy diagnoses were done 30 days after FTAI. The effects of treatments on CL area and serum P4 levels were analysed by ANOVA (Proc GLM, SAS Institute Inc., Cary, NC, USA) and pregnancy rates compared by chi-square (Proc CATMOT, SAS). The induction of accessory CL determined on Day 7 was 44% in cows treated with hCG and not observed in the control group. The area of the CL on Day 7 was significantly higher (P < 0.01; 3.37 ± 2.56 v. 2.56 ± 0.22 cm2) in the hCG group. Despite the increase in CL size, the mean levels of P4 on Days 4, 7, 10, 14, and 30 post-AI indicated no difference (P > 0.05) in CL function between control and hCG-treated cows. On Day 30, pregnancy rates were not different (P = 0.08), at 46.7 and 55% for control and hCG-treated cows, respectively. In conclusion, administration of 1.500 IU of hCG on Day 4 post-FTAI did not improve pregnancy rate in suckled beef cows.


2004 ◽  
Vol 16 (2) ◽  
pp. 212 ◽  
Author(s):  
T. Nishisouzu ◽  
M. Sugawara ◽  
S. Aoki ◽  
K. Kishida ◽  
M. Moriyoshi ◽  
...  

Treatments with GnRH and PGF2α for synchronization of ovulation has resulted in acceptable pregnancy rates after fixed-time artificial insemination in dairy cows without estrus detection. The objective of the present study was to evaluate the practicability of ovulation synchronization (Ovsynch, Pursley JR et al. 1995 Theriogenology 44, 915–923) in dairy cattle using GnRH and PGF2α for the embryo transfer recipients. Dairy cattle (cows; n=100, heifers; n=88) were randomly allocated to one of two groups. The control group (cows; n=45, heifers; n=37) was composed of cows in natural estrus. The ovulation synchronization group (cows; n=55, heifers; n=51) was treated with an intramuscular injection of 100μg of GnRH at a random stage of the estrous cycle. Seven days later, the cattle received PGF2α (Cows; 25–30mg) or PGF2α analog (Heifers; 0.5mg) in order to regress the corpora lutea (CL). Forty-eight hours later, cows and heifers received a second injection of 100μg GnRH. Embryo transfer was carried out 7 days after the second injection of GnRH in the ovsynch group and 7 days after estrus in the control group. The cattle judged to have CL 17mm were classified as acceptable recipients. The size of the follicles and the CL were determined to be of estrus stage and embryo transfer by means of ultrasonography. The mean numbers of follicles and CL were analyzed by ANOVA, while pregnancy rates were analyzed by chi-square test. The results are presented in the Table. The proportion of cows and heifers determined to be acceptable embryo transfers was not different between the control group and the ovsynch group. There were no differences in the proportion of acceptable embryo transfers between the control group and the ovsynch group. Follicle diameter at the time of estrus in the control group (cows; 20.7±0.7mm, heifers; 16.8±0.5mm) were significantly larger than that of the ovsynch group (cows; 18.0±1.0mm, heifers; 14.7±0.2mm) (P&lt;0.05). Although CL diameter at the time of embryo transfer in heifers showed no differences between the control group and the ovsynch group (25.0±1.0mm v. 22.8±1.5mm), The CL diameter of the control cow group was larger than that of the ovsynch group (29.8±0.7mm v. 26.1±1.0mm, P&lt;0.05). However, no differences in pregnancy rate were seen between the control group and the ovsynch group. These results suggest that ovsynch can be effectively applied in an embryo transfer program for cattle. Table 1 Proportion of acceptable embryo transfer recipients and pregnancy rate in dairy cattle in the control ovsynch groups


2005 ◽  
Vol 17 (2) ◽  
pp. 156 ◽  
Author(s):  
M. Colazo ◽  
M. Rutledge ◽  
J. Small ◽  
J. Kastelic ◽  
L. Siqueira ◽  
...  

The objectives were to investigate the effects of pretreatment with a used CIDR on follicle size and ovulation rate in cows after an injection of GnRH, and treatment with eCG at the time of PGF on preovulatory follicle size and fertility in cows subjected to a Cosynch protocol. Lactating crossbred beef cows (n = 292), 2 to 12 years of age were allocated to two groups to receive either a used CIDR (Bioniche Animal Health; Belleville, Ontario, Canada) for 15 days or no treatment (Control). At CIDR removal (Day 0), all cows received 100 μg of GnRH i.m. (Cystorelin, Merial Canada Inc., Victoriaville, Quebec, Canada). On Day 7, all cows received 500 μg of cloprostenol i.m. (PGF; Estrumate, Schering-Plough Animal Health, Pointe-Claire, Quebec, Canada) and were further allocated to receive either 400 IU of eCG i.m. (Pregnacol; Bioniche Animal Health) or no treatment (2 × 2 factorial design; n = 73 per group). On Day 9 (54 h after PGF), cows were given 100 μg of GnRH i.m., concurrent with timed AI (TAI). Transrectal ultrasonographic examinations were done on a subset of approximately 40 cows in each group on Days −15, 0, 7, and 9 to assess ovarian structures, and on all cows on Day 37 to confirm pregnancy. Data were analyzed by SAS CATMOD and ANOVA. Overall, 53% of cows had a CL present on Day −15 (P = 0.23). At first GnRH (Day 0), fewer CIDR-treated cows than Control cows had a CL (15.2 vs. 85.0%, respectively; P < 0.001), while mean (± SEM) diameters of the dominant follicle were larger in CIDR-treated cows (18.2 ± 0.4 vs. 13.8 ± 0.4 mm, respectively; P < 0.001). Moreover, the proportion of cows that ovulated following the first GnRH was higher (P < 0.001) in CIDR-treated (75.0%) than Control (48.7%) cows. Eight (10.0%) cows presynchronized with a CIDR did not ovulate and had a luteinized follicle (31.7 ± 1.9 mm) at the time of PGF. Although CIDR-treated cows had larger (P < 0.002) dominant follicles than Control cows on Day 9 (16.6 ± 0.3 vs. 15.2 ± 0.3 mm), presynchronization did not affect fertility (53.4 vs. 54.1%, respectively). However, diameter of the dominant follicle at TAI in cows that became pregnant was smaller in CIDR-treated vs. Control cows (15.3 ± 0.3 vs. 16.6 ± 0.3; P < 0.005). Treatment with eCG on Day 7 did not affect (P = 0.17) the diameter of the dominant follicle at TAI, but tended (P = 0.06) to increase pregnancy rate (58.9 vs. 48.6%). Furthermore, pregnancy rate tended to be higher (P = 0.08) in Control cows given eCG (47/73, 64.4%) than in the Control- (32/73, 43.8%), CIDR- (39/73, 53.4%) or CIDR/eCG- (39/73, 53.4%) treated cows. In addition, pregnancy rate was affected by parity; 2-yr-old cows had a lower (P < 0.04) pregnancy rate than older cows (42.9, 58.7, and 58.2% for 2, 3–4, and >5 years, respectively). Treatment with eCG increased pregnancy rate by 33% (P < 0.03) in 2-yr-old Control cows. In summary, presynchronization with a used CIDR prior to a Cosynch protocol increased the proportion of cows responding to the first GnRH. Although CIDR-treated cows had a smaller dominant follicle at TAI, pregnancy rate was not affected. Treatment with eCG increased fertility in Control cows; eCG may be useful in GnRH-based protocols in lactating beef cows.


2004 ◽  
Vol 16 (2) ◽  
pp. 129 ◽  
Author(s):  
J.P. Kastelic ◽  
M.G. Colazo ◽  
J.A. Small ◽  
D.R. Ward ◽  
R.J. Mapletoft

The objective was to characterize ovarian follicular dynamics in beef cows treated with a CIDR (Bioniche Animal Health; Belleville, Ontario, Canada) and an injection of estradiol-17β (E2), with or without progesterone (P4), late in the estrous cycle. Previously synchronized, non-lactating, crossbred beef cows (n=36) received a CIDR (Day 0) 16 to 18 days after ovulation and were randomly allocated to one of three treatment groups: no further treatment (Control, n=12), an injection of 5mg E2 (E2, n=12), or 5mg E2 plus 100mg P4 (E2P4, n=12; both from Sigma Chemical Co., St.Louis, MO, USA) i.m. in 2mL canola oil. On Day 7, CIDR were removed and cows received 500μg i.m. of cloprostenol (Estrumate, Schering Plough Animal Health, Pointe-Claire, Quebec, Canada). Ovaries were examined once daily by transrectal ultrasonography to detect ovarian follicle growth profiles, and determine the time of ovulation. Blood samples were taken daily for progesterone determination. Data were analyzed by ANOVA (LSD and Bartlett’s tests), Student’s t-test and chi-square procedures. Diameter of the CL and the dominant follicle, and progesterone concentration on Day 0 did not differ among groups (P=0.6; overall mean (±SD), 16.8±2.7mm, 14.1±2.0mm, and 1.5±1.9ngmL, respectively). Thirteen cows ovulated within 3 days of treatment (50% of E2- and E2P4-treated cows and 8.3% of Control cows; P=0.05); cows that ovulated had smaller CL diameters (15.2±1.7 v. 17.7±2.7mm; P&lt;0.004) and lower progesterone concentrations (0.4±0.2 v.2.1±2.2ngmL; P&lt;0.001) at the time of treatment. Follicular wave emergence occurred within 7 days in 4/12 Control cows, 10/12 E2-treated cows, and 10/12 E2P4-treated cows (P&lt;0.01). Although the interval from treatment to wave emergence did not differ among treatments (P=0.8; overall, 3.4±1.5 days), follicular wave emergence was more synchronous (P&lt;0.004) in the E2 group than in the Control or E2P4 groups. At CIDR removal, dominant follicle diameter was larger (P&lt;0.02) in the Control group (15.9±5.5mm) than in the E2 (11.9±1.8mm) or E2P4 (11.5±3.4mm)groups, but dominant follicle diameter was less variable (P&lt;0.003) in the E2 group than in the other two groups. Three cows did not ovulate after CIDR removal; two in the Control group and one in the E2P4 group. Interval to ovulation was shorter (P&lt;0.05) in the Control group (70.8±10.5h)than in the E2 (87.0±9.0h) or E2P4 (86.2±7.2h) groups, and the intervals to ovulation in cows that ovulated following treatment (91.0±8.0h) was longer (P&lt;0.001) than in those that did not (76.6±9.6h). In summary, treatment of cows with an estradiol-progesterone protocol late in the estrous cycle resulted in ovulation (50.0%), atresia (33.3%) or persistence (16.6%) of the dominant follicle present at that time. As length of follicular dominance and timing of ovulation were affected, fertility may be impaired following AI.


2005 ◽  
Vol 17 (2) ◽  
pp. 159 ◽  
Author(s):  
R. Mapletoft ◽  
M. Colazo ◽  
L. Siqueira ◽  
J. Small ◽  
M. Rutledge ◽  
...  

Two experiments were designed to evaluate strategies to improve fertility with Cosynch-CIDR protocols in cattle. The first experiment investigated the effect of low levels of progesterone prior to a Cosynch-CIDR protocol. On Day 0, lactating beef cows (n = 34) and heifers (n = 37) were placed in two groups to receive 500 μg cloprostenol (PGF; Estrumate, Schering-Plough Animal Health, Pointe-Claire, Quebec, Canada) or a twice-used CIDR (Bioniche Animal Health, Belleville, Ontario, Canada) for 5 days (Pretreatment) or no treatment (Control). On Day 5, used CIDRs were removed and all cattle received a new CIDR (Pfizer Animal Health, Montreal, Quebec, Canada) and 100 μg GnRH (Cystorelin, Merial Canada Inc, Victoriaville, Quebec, Canada). On Day 12, CIDR were removed and PGF was given. A second GnRH was given concurrent with timed AI (TAI) on Day 14 (54–56 h after PGF). Cattle were examined by transrectal ultrasonography for CL and follicle development, and for confirmation of pregnancy (Days 42 to 49). Diameter of the dominant follicle on Day 5 was larger and more variable in cows than in heifers (15.5 ± 5.6 vs. 11.4 ± 3.5 mm, respectively; means, P < 0.001; variance, P < 0.003), and tended to be larger in the Pretreatment group (14.3 ± 4.9 vs. 12.6 ± 5.2 mm; P = 0.13). More Pretreated (60.0%) than Control (36.1%) cattle (P < 0.005), and more cows (64.7%) than heifers (32.4%; P < 0.03) ovulated following the first GnRH. At the time of TAI, 5 (13.5%) heifers had already ovulated (P < 0.03). Diameter of the preovulatory follicle was affected by parity (P < 0.001), but not Pretreatment (P = 0.4), and tended to be larger in heifers that became pregnant (P = 0.13). Pregnancy rate was not affected by parity (P = 0.71), or pretreatment (P = 0.34); pretreatment tended to increase pregnancy rate in heifers (63.2 vs. 38.9%; P = 0.19). The second experiment evaluated the use of eCG in a Cosynch-CIDR protocol in beef heifers. Beef heifers (n = 127) were fed 0.5 mg/head/day of MGA (Pfizer Animal Health) for 15 d; 12 d after the last feeding (designated as Day 0) heifers received a CIDR and 100 μg GnRH. On Day 7, CIDR were removed, and heifers received PGF, and were randomly placed in 2 groups to receive 300 IU of eCG (Pregnacol; Bioniche Animal Health) or no treatment (Control). On Day 9 (54–56 h after PGF), all heifers received 100 μg GnRH, concurrent with TAI. Ultrasonographic examinations were done as in the first experiment. Overall, 79.5% of the heifers had a CL, and 9.4% had a luteinized follicle on Day 0. Seventy-eight heifers (61.4%) ovulated following the first GnRH, and those that ovulated had a less variable preovulatory follicle size than those that did not (13.7 ± 1.7 vs. 13.8 ± 2.3 mm; means, P = 0.76; variance, P < 0.01). However, there was no difference in preovulatory follicle size (P = 0.63), or pregnancy rate (49.2 vs. 53.1%; P = 0.7) for eCG-treated vs. Control heifers. In summary, pretreatment with a twice-used CIDR plus PGF increased the proportion of cattle that ovulated to the first GnRH, but not preovulatory follicle size or fertility in cows; fertility tended to be improved in heifers. Treatment with eCG did not increase preovulatory follicle size or fertility in heifers subjected to an Cosynch-CIDR protocol.


2010 ◽  
Vol 22 (1) ◽  
pp. 170 ◽  
Author(s):  
L. A. Lima ◽  
V. G. Pinheiro ◽  
J. R. Cury ◽  
C. M. Barros

There are reports in the literature indicating that use of eCG improves pregnancy rates in Bos indicus anestrous cows treated with a progesterone-based fixed-time AI (FTAI) protocol. More recently, replacement of eCG by FSH in FTAI protocols was reported to have beneficial effects (Bos indicus) or no effect (Bos taurus) on pregnancy rates. In the present experiment the effects of eCG and FSH on pregnancy rates were compared in an FTAI protocol. Primiparous lactating Nellore cows (40 to 80 days postpartum, n = 421) with a body condition score of 2.5 to 3.0 (on a 1 to 5 scale) were randomly allocated in 3 groups: Control (CTR), eCG, and FSH. In the control group, all animals received a progesterone (P4)-releasing intravaginal device (1.55 g, PRID®, Ceva Sante Animale S.A., Libourne, France) and 2.5 mg of estradiol benzoate (EB, i.m. Estrogin®, Farmavet, São Paulo, Brazil), on Day 0 (D0). Eight days later (D8), at the time of the intravaginal device withdrawal, PGF2α (150 μg, D-cloprostenol, i.m. Prolise®, ARSA S.L.R., Buenos Aires, Argentina) was administered. Twenty-four hours after PRID removal, cows were treated with EB (1.0 mg, i.m.), and FTAI was done 30 to 36 h later. In the eCG and FSH groups, the cows were treated with 20 mg of FSH (Folltropin-V®, i.m. Bioniche, Belleville, Canada) or400IU of eCG (Novormon®, i.m. Syntex, Buenos Aires, Argentina), respectively, at the time of PGF2α administration. Ovarian ultrasonography (Aloka SSD 500, 7.5-MHz probe, Aloka, Tokyo, Japan) was performed 10 days prior to and at the beginning of FTAI protocol to select the animals in postpartum anestrous (absence of CL in both examinations). The pregnancy diagnosis was performed by ultrasonography 30 days after FTAI. Data were analyzed by logistic regression (SAS Institute, Cary, NC, USA). Cows treated with eCG had a higher pregnancy rate (41.5%, 95/229; P < 0.05) than those treated with FSH (22.7%, 22/97) or in the control group (26.3%, 25/95). Pregnancy rates of animals treated with FSH did not differ (P > 0.05) from those in the control group. These results indicated that, in lactating primiparous anestrous Nellore cows, the use of eCG in a FTAI protocol improves the pregnancy rate, whereas FSH has no beneficial effect. V. G. Pinheiro received a fellowship from FAPESP (São Paulo, Brazil). The authors are grateful to Ceva Animal Health for providing the intravaginal devices (PRID®) used in this experiment.


Author(s):  
Thaslima Nandhini Js ◽  
Savitha Basker G ◽  
Vishnupriya V

Objective: Metabolic syndrome is a cluster of disease condition characterized by truncal obesity, hypertriglyceridemia, elevated blood pressure, and insulin resistance. An excessive circulating uric acid (UA) level even within normal range is always comorbid with metabolic syndrome and its components. The aim of the current study was to investigate the association between metabolic syndrome and serum UA level.Methods: A total of 60 subjects were divided into two groups of healthy (30 individuals) and metabolic syndrome patients (30 individuals) from dental outpatient department of Saveetha Dental College and Hospitals. 5 ml of fasting venous blood was collected in the plain collection tubes and centrifuged, and then serum was separated. Then, the serum was used to analyze the fasting blood glucose, serum triglycerides (TGLs), and serum UA by GOD-POD, enzymatic colorimetric, and uricase method, respectively. A statistical analysis was performed using Student’s t-test. p<0.05 was considered to be statistically significant.Result: Mean body mass index (BMI), fasting blood sugar (FBS), TGL, and UA level of control group were 23.36±1.81, 84.45±13.1, 110.9±22.6, and 3.48±1.21 respectively. Mean BMI, FBS, TGL, and UA level of study group were 35.24±3.04, 122.85±23.3, 212.1±39.6 and 9.08±2.63 respectively. There is a significant difference between these two groups with p<0.0001.Conclusion: This study showed that those individuals with metabolic syndrome have higher UA level that indicates hyperuricemia which is a significant predictor of metabolic syndrome.


2010 ◽  
Vol 14 (1) ◽  
pp. 15 ◽  
Author(s):  
G. QUADRI ◽  
N. NATALE ◽  
C. SPREAFICO ◽  
C. BELLONI ◽  
D. BARISANI ◽  
...  

Intravesical prostaglandin E2 is effective in the recovery of spontaneous voiding after transvaginal reconstruction of the pubocervical fascia and short arm sling according to Lahodny. The aim of the study was to compare the effects of intravesical prostaglandin E2 in the prevention of urinary retention after transvaginal reconstruction of the pubocervical fascia and short arm sling according to Lahodny. STUDY DESIGN: From November 1996 to June 1999 fifty women underwent the Lahodny procedure for moderate/severe cystocele and stress urinary incontinence. Women were randomly assigned to 1 of the 2 study groups: intravesical prostaglandin E2 versus controls. Data obtained were analyzed with the Student t test and the Fisher exact test. RESULTS: Two patients of the treatment group had to be excluded from the study, one because of the wrong measurement of the post-voidal residual volume and another due to a fastidious burning sensation which appeared immediately after prostaglandin instillation and required the suspension of the treatment. No other side effects such as nausea, vomiting, diarrhea or hyperthermia were observed. Patients who underwent the prostaglandin E2 treatment showed a recovery of spontaneous voiding after 7.9&plusmn;6.7 days, whereas this interval was significantly longer in the control group, being 12.9&plusmn;9.7 days (p=0.04, Two tailed Unpaired Student's T test). CONCLUSION: The effectiveness and the low associated morbidity mark the treatment with intravesical prostaglandin E2 useful in the recovery of normal voiding after transvaginal pubocervical fascia reconstruction and short arm sling with the procedure according to Lahodny.


2018 ◽  
Vol 5 (2) ◽  
pp. 105-108
Author(s):  
Lijo Isaac ◽  
A. P. Nirmal Raj ◽  
Reshma Karkera ◽  
R Naveen Reddy

Very little studies were done on relationship of the dental status and the nutritional status. The present study was done to study relation between edentulism and the presence of anemia. The study was included of 46 adult patients with edentulism and same numbers of patients were taken as controls. The results were tabulated and analyzed with the help of IBM SPSS statistics 20 using student’s t test. The hemoglobin levels were lower in the edentulous patients that that of the control group. The present study had shown that the nutritional status were poor resulting in anemia in case of edentulous patients as compared to control group with the same age group.  


Sign in / Sign up

Export Citation Format

Share Document